Off-Label With Altasciences podcast

EP3: The Future of Sampling Is Here—Almost

0:00
55:55
Rewind 15 seconds
Fast Forward 15 seconds

Host Lisa Sanford is joined by Neil Spooner (PCSIG), Katty Wan (Pfizer), Enaksha Wickremsinhe (Gates Medical Research Institute), and Jeff Plomley (Altasciences) to discuss microsampling and the role it plays in a patient-centric sampling approach.

With reduced sample volume, as well as the ability to provide additional options and convenience to patients, this episode showcases the “big” potential and impact of this innovative “small” technique. From training, logistical, and implementation challenges, to regulations and device dependency, learn more about the building momentum in both bioanalytical and clinical applications.

(00:00) - Introduction: The rise of patient-centric sampling

(00:53) - Meet the microsampling panel

(01:24) - What Is microsampling?

(03:00) - Advances driving microsampling forward

(06:44) - Which assays are compatible with microsampling?

(08:55) - Putting patient choice at the center

(11:40) - How COVID-19 accelerated at-home sampling

(14:05) - Barriers to widespread adoption

(15:25) - Training patients for at-home collection

(18:45) - Navigating logistics and sample returns

(22:35) - Regulatory challenges across global studies

(26:30) - Device variability and sample quality

(32:30) - Building patient-centric sampling into clinical trials

(35:40) - Expanding at-home sampling beyond PK

(39:10) - How the industry can drive adoption

(42:15) - Education, collaboration, and the patient-centric sampling community

(46:40) - The future of microsampling technology

(50:07) - Bold predictions for patient-centric sampling

(55:28) - Closing thoughts

About Off-Label With Altasciences:

Off-Label presents candid conversations about the drug development industry from an insider perspective. We discuss trending topics and new developments alongside industry experts. Whether you’re drug development-curious or a seasoned veteran, enjoy as we peel back the label.

About Altasciences:

Altasciences is a drug development organization dedicated to safely accelerating early-phase development for biotech, biopharmaceutical, and pharmaceutical companies. By combining the scale and expertise of a large CRO/CDMO with the flexibility and personalized approach of a mid-size partner, Altasciences delivers unified solutions across nonclinical, clinical, bioanalytical, formulation, and manufacturing services. Through intentional integration and true collaboration, the company removes barriers from lead candidate selection to clinical proof of concept—helping sponsors save time, reduce complexity, and make confident, data-driven decisions that enable earlier returns on investment. Guided by over 30 years of experience and a commitment to quality, integrity, and partnership, Altasciences enables clients to reach critical milestones faster and with greater confidence. Altasciences… Drug Development, Reimagined.™

More episodes from "Off-Label With Altasciences"